Gemcabene for the Treatment of Pediatric NAFLD: A Phase 2a Study
Phase of Trial: Phase II
Latest Information Update: 19 Nov 2018
At a glance
- Drugs Gemcabene (Primary)
- Indications Non-alcoholic fatty liver disease
- Focus Proof of concept; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 13 Aug 2018 According to Gemphire Therapeutics media release, this trial was terminated due to unexpected liver problems observed in the patients that underwent 12-week MRI-PDFF imaging scans.
- 10 Aug 2018 According to Gemphire Therapeutics media release, the Data and Safety Monitoring Board (DSMB) at Emory University School of Medicine overseeing this trial has recommended that the trial be terminated due to unanticipated problems.